~Basil

There is a reason why vaccine makers and bought-off politicians are racing to vaccinate 100 million Americans by July 4th. If prior population studies are any indication, by July 2021 it is likely a safer and more effective vaccine than RNA vaccines (Pfizer/Moderna) will be revealed in a large-group placebo vs inoculum study taking place in Canada.

If you are in torment over whether to vaccinate against COVID-19 or not, or forced to mull over vaccination because your employer demands you submit to immunization as a condition of employment, hold on, at least till July 2021, when the results of a major vaccine study will likely be revealed. Though existing data is so compelling one would wonder why anyone fearful of COVID19 would hesitate to undergo immunization immediately.

A major drawback of the RNA vaccines now being pushed upon wary Americans is that they pose the problem of antibody dependent enhancement (ADE) – – your own antibodies attack your lungs and other internal organs. ADE is usually a delayed reaction. And ADE is beginning to occur among vaccinated populations. ADE strikes younger populations. According to some reports, vaccine-induced antibodies against COVID-19 are not providing lasting immunity.

T-cells are known to protect against severe infection and re-infection. T-cell memory provides lasting immunity. T-cell directed vaccines stimulate clearance of viruses and avoid antibody-dependent enhanced disease.

These same researchers reveal there already is a proven safe and effective vaccine that protects against COVID-19 via activation of T-cells – – the Bacille Calmette-Guerin (BCG) vaccine for another infectious lung disease — tuberculosis. It is derived from a mycobacterium (mycobacterium bovis) found in cattle. It is a “live” but attenuated bacterium.

BCG vaccine mechanism: trained immunity

The BCG vaccine is not widely used in the US.

While the BCG vaccine does activate T-cells, it also works independent of B or T cells. BCG vaccine affords “trained immunity.” It works via epigenetic re-programming, that is, gene protein making, which essentially what the RNA vaccines pretend to do. This is called epigenetic memory.

This type of trained immunity is independent of B and T-cell activation and is accomplished via white blood cells (monocytes, macrophages, natural-killer cells). For physicians who must to know precisely how it works, BCG vaccine targets known cell surface receptors (toll-like TLR2 and TLR4; complement receptors CR3-CR4; NOD-like receptors).

BCG vaccine is so safe it is approved for use with neonates, children and adults for almost 100 years. Buy New $69.99 (as of 04:14 EDT - Details)

The BCG vaccine also confers immunity against Staphylococcus and Candida organisms in additional tuberculosis bacilli. BCG vaccine is also useful in preventing multiple sclerosis and cancer.

BCG Vaccine and COVID-19

Evidence for the BCG vaccine to quell COVID-19 infections is compelling.

A study published in November of 2020 confirms that BCG vaccine protects health care workers from COVID-19 infection. Healthcare workers previously inoculated with BCG vaccine experienced a marked decrease in COVID-19 infection.

Population studies reveal the potential of BCG vaccination. Epidemiologists project a 37% decrease in COVID-19 mortality between East Germany which was vaccinated with BCG vaccine and not West Germany.

Statisticians claim there would have been 80% fewer COVID-19 deaths in the US by March 29, 2020 had the country employed mandatory BCG vaccination since 2000.

Worldwide, TB kills more people than COVID-19. Now “two birds could be knocked out with one stone.”